Medapharma
Pfeil  

MEDICAL STAFF/JOURNALISTS
Lay Media
Press releases 2010
Press releases 2009
Press releases 2008
Press releases 2007
Press releases 2006
Basic press kit
Graphics/photos
Medical Press
 

Press - Lay Media

The following articles are available:

Modern H1-Blocker to Combat the Winter Allergy
Monday, 19. November 2007

People with red, itchy and runny noses are a common sight in every doctor’s surgery during the winter months. Not all of them have a flu-like viral infection though. In many patients, the cause is allergic rhinitis. Besides pollen, this can be caused by foods, pets and house dust mites. The house dust mite allergy in particular has high season during cold, damp weather. Colloquially, this is referred to as the ‘winter allergy’. The topical antihistamine azelastine (Allergodil®) H1-type blocker not only effectively reduces the symptoms of allergic rhinitis, but thanks to its rapid response and its good tolerability, it also contributes to a significantly increased quality of life for patients.
more>>>

Tips for Reducing the Symptoms of a House Dust Mite Allergy
Monday, 19. November 2007

  • Ventilate living rooms and especially rooms which are exposed to moisture four times a day for between five and ten minutes each with the windows wide open.

  • more>>>

    House Dust Mites
    Monday, 19. November 2007

    House dust mites do not appear as a result of insufficient hygiene, but are in fact natural cohabitants of ours. They belong to the arachnid family. Worldwide, there are approximately 150 different species, and they measure 0.1 to 0.5 mm in size.
    more>>>

    Would you have guessed? European and American noses react the same
    Sunday, 01. April 2007

    One spray of Azelastine in each nostril twice a day is enough for the treatment of hay fever. That was the conclusion of a recent study conducted by American scientists on a group of over 500 patients. Background info: the nasal spray is approved for two sprays per nostril in the U.S., whereas most of the European countries have approved the dosage of one spray per nostril. The study proves that the Europeans have got it right.
    more>>>

    New product information website
    Thursday, 01. March 2007

    MEDA Pharma, headquartered in Solna, Sweden, has established a new informational website for patients concerning allergy therapy with the active ingredient Azelastin (i.e. in Allergodil® akut).
    more>>>